Why the study?
Anticancer treatments induce significant cardiac adverse effects, but existing strategies to prevent cardiotoxicity are not completely safe or satisfactory, with some even contributing to cancer induction.
Can agents targeting specific GPCRs prevent or treat cardiotoxicity induced by anticancer treatments?
Can agents targeting specific GPCRs prevent or treat cardiotoxicity induced by anticancer treatments?
This review highlights the potential of targeting specific GPCRs to develop novel, safe cardioprotective therapies against anticancer drug-induced cardiotoxicity.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for GPCR-targeted agents in anticancer cardiotoxicity; prospective trials needed before clinical adoption.
Novel anticancer medicines, including targeted therapies and immune checkpoint inhibitors, have greatly improved the management of cancers. However, both conventional and new anticancer treatments induce cardiac adverse effects, which remain a critical issue in clinic. Cardiotoxicity induced by anti-cancer treatments compromise vasospastic and thromboembolic ischemia, dysrhythmia, hypertension, myocarditis, and cardiac dysfunction that can result in heart failure. Importantly, none of the strategies to prevent cardiotoxicity from anticancer therapies is completely safe and satisfactory. Certain clinically used cardioprotective drugs can even contribute to cancer induction. Since G protein coupled receptors (GPCRs) are target of forty percent of clinically used drugs, here we discuss the newly identified cardioprotective agents that bind GPCRs of adrenalin, adenosine, melatonin, ghrelin, galanin, apelin, prokineticin and cannabidiol. We hope to provoke further drug development studies considering these GPCRs as potential targets to be translated to treatment of human heart failure induced by anticancer drugs.
No takes yet. Share an insight, caveat, or question.
Audebrand et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: